Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA3 | P0DMS8 | 5/20 | 0.98 |
| ▸ | SLC29A1 | Q99808 | 4/20 | 0.98 |
| ▸ | TP53 | P04637 | 3/20 | 0.98 |
| ▸ | PAX8 | Q06710 | 3/20 | 0.98 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.98 |
| ▸ | MITF | O75030 | 1/20 | 0.98 |
| ▸ | LMNA | P02545 | 1/20 | 0.98 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.73 |
| ▸ | ADORA2A | P29274 | 2/20 | 0.68 |
| ▸ | ADORA1 | P30542 | 2/20 | 0.68 |
| ▸ | TSHR | P16473 | 1/20 | 0.68 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.68 |
| ▸ | STAT6 | P42226 | 1/20 | 0.68 |
| ▸ | GMNN | O75496 | 1/20 | 0.68 |
| ▸ | BLM | P54132 | 1/20 | 0.68 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.68 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25170466 | 1.00 | ADORA3 (0.98) | ADORA3SLC29A1TP53PAX8SMN1; SMN2 | |
| SCHEMBL29100470 | 1.00 | ADORA3 (0.98) | ADORA3SLC29A1TP53PAX8SMN1; SMN2 | |
| Kinetin Riboside SCHEMBL14713468 | 0.99 | ADORA3 (1.00) | ADORA3SLC29A1TP53PAX8SMN1; SMN2 | |
| Kinetin Riboside SCHEMBL217034 | 0.99 | ADORA3 (1.00) | ADORA3SLC29A1TP53PAX8SMN1; SMN2 | |
| Kinetin Riboside SCHEMBL3339041 | 0.99 | ADORA3 (1.00) | ADORA3SLC29A1TP53PAX8SMN1; SMN2 | |
| Kinetin Riboside SCHEMBL3190271 | 0.99 | ADORA3 (1.00) | ADORA3SLC29A1TP53PAX8SMN1; SMN2 | |
| Kinetin Riboside SCHEMBL14713232 | 0.99 | ADORA3 (1.00) | ADORA3SLC29A1TP53PAX8SMN1; SMN2 | |
| Kinetin Riboside SCHEMBL19583061 | 0.99 | ADORA3 (1.00) | ADORA3SLC29A1TP53PAX8SMN1; SMN2 | |
| Kinetin Riboside SCHEMBL3190252 | 0.99 | ADORA3 (1.00) | ADORA3SLC29A1TP53PAX8SMN1; SMN2 | |
| Kinetin Riboside SCHEMBL29564117 | 0.99 | ADORA3 (1.00) | ADORA3SLC29A1TP53PAX8SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12358868-B2 | Chemical derivatives and methods for synthesizing and compounding chemical derivatives related to capsaicin palmitate and capsaicin prodrugs | CHORDA PHARMA, INC. (US) | 2025-07-15 | — | — | US | disclosed |
| US-20230406816-A1 | CHEMICAL DERIVATIVES AND METHODS FOR SYNTHESIZING AND COMPOUNDING CHEMICAL DERIVATIVES RELATED TO CAPSAICIN PALMITATE AND CAPSAICIN PRODRUGS | CHORDA PHARMA INC (US) | 2023-12-21 | — | — | US | disclosed |
| US-11773055-B2 | Chemical derivatives and methods for synthesizing and compounding chemical derivatives related to capsaicin palmitate and capsaicin prodrugs | CHORDA PHARMA, INC. (US) | 2023-10-03 | — | — | US | disclosed |
| US-20220168259-A1 | CHEMICAL DERIVATIVES AND METHODS FOR SYNTHESIZING AND COMPOUNDING CHEMICAL DERIVATIVES RELATED TO CAPSAICIN PALMITATE AND CAPSAICIN PRODRUGS | CHORDA PHARMA, INC. | 2022-06-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11773055-B2 | Chemical derivatives and methods for synthesizing and compounding chemical derivatives related to capsaicin palmitate and capsaicin prodrugs | HCAR2, HCAR3, TRPV1 | ADORA3 1020/4885SLC29A1 2341/4885TP53 4591/4885 |
| US-12358868-B2 | Chemical derivatives and methods for synthesizing and compounding chemical derivatives related to capsaicin palmitate and capsaicin prodrugs | HCAR2, HCAR3, TRPV1 | ADORA3 1020/4885SLC29A1 2341/4885TP53 4591/4885 |
| US-20220168259-A1 | CHEMICAL DERIVATIVES AND METHODS FOR SYNTHESIZING AND COMPOUNDING CHEMICAL DERIVATIVES RELATED TO CAPSAICIN PALMITATE AND CAPSAICIN PRODRUGS | HCAR2, HCAR3, TRPV1 | ADORA3 1020/4885SLC29A1 2341/4885TP53 4591/4885 |
| US-20230406816-A1 | CHEMICAL DERIVATIVES AND METHODS FOR SYNTHESIZING AND COMPOUNDING CHEMICAL DERIVATIVES RELATED TO CAPSAICIN PALMITATE AND CAPSAICIN PRODRUGS | HCAR2, HCAR3, TRPV1 | ADORA3 1020/4885SLC29A1 2341/4885TP53 4591/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.